These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28029019)

  • 1. Osteoblasts Are the Centerpiece of the Metastatic Bone Microenvironment.
    Jeong HM; Cho SW; Park SI
    Endocrinol Metab (Seoul); 2016 Dec; 31(4):485-492. PubMed ID: 28029019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
    Chung LW; Baseman A; Assikis V; Zhau HE
    J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bone microenvironment in metastasis; what is special about bone?
    Bussard KM; Gay CV; Mastro AM
    Cancer Metastasis Rev; 2008 Mar; 27(1):41-55. PubMed ID: 18071636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of cancer metastasis to the bone.
    Yin JJ; Pollock CB; Kelly K
    Cell Res; 2005 Jan; 15(1):57-62. PubMed ID: 15686629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype.
    Loberg RD; Logothetis CJ; Keller ET; Pienta KJ
    J Clin Oncol; 2005 Nov; 23(32):8232-41. PubMed ID: 16278478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The critical role of the bone microenvironment in cancer metastases.
    Casimiro S; Guise TA; Chirgwin J
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):71-81. PubMed ID: 19616059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-stromal interactions in bone metastasis.
    Nannuru KC; Singh RK
    Curr Osteoporos Rep; 2010 Jun; 8(2):105-13. PubMed ID: 20425618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the role of bone marrow stromal cells on bone metastases.
    Buenrostro D; Park SI; Sterling JA
    Biomed Res Int; 2014; 2014():875305. PubMed ID: 25054153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone metastasis in prostate cancer: molecular and cellular mechanisms (Review).
    Ye L; Kynaston HG; Jiang WG
    Int J Mol Med; 2007 Jul; 20(1):103-11. PubMed ID: 17549396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets.
    Wood SL; Pernemalm M; Crosbie PA; Whetton AD
    Cancer Treat Rev; 2014 May; 40(4):558-66. PubMed ID: 24176790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Encounter of cancer cells with bone. Development of bone metastasis-specific targeting therapy].
    Hayashi S; Hanamura T
    Clin Calcium; 2011 Mar; 21(3):389-96. PubMed ID: 21358060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting Tumor-Stromal Interactions in Breast Cancer Bone Metastasis.
    Kang Y
    Endocrinol Metab (Seoul); 2016 Jun; 31(2):206-12. PubMed ID: 27184014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current trials using bone-targeting agents in prostate cancer.
    Tu SM; Lin SH
    Cancer J; 2008; 14(1):35-9. PubMed ID: 18303481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
    Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
    Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of tumor metastasis to the bone: challenges and opportunities.
    Reddi AH; Roodman D; Freeman C; Mohla S
    J Bone Miner Res; 2003 Feb; 18(2):190-4. PubMed ID: 12568395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions.
    Loberg RD; Gayed BA; Olson KB; Pienta KJ
    J Cell Biochem; 2005 Oct; 96(3):439-46. PubMed ID: 15988761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases.
    Hiraga T
    Expert Opin Investig Drugs; 2016; 25(3):319-34. PubMed ID: 26778342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic breast cancer induces an osteoblast inflammatory response.
    Kinder M; Chislock E; Bussard KM; Shuman L; Mastro AM
    Exp Cell Res; 2008 Jan; 314(1):173-83. PubMed ID: 17976581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of hepatocyte growth factor in the development of bone metastasis of a mouse mammary cancer cell line, BALB/c-MC.
    Ono K; Kamiya S; Akatsu T; Nakamura C; Li M; Amizuka N; Matsumoto K; Nakamura T; Kugai N; Wada S
    Bone; 2006 Jul; 39(1):27-34. PubMed ID: 16459153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.
    Dushyanthen S; Cossigny DA; Quan GM
    Cancer Growth Metastasis; 2013; 6():61-80. PubMed ID: 24665208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.